NeuroOne Medical Technologies Corporation (NMTC) Q1 2026 Earnings Call Transcript

Understand this faster with AI
SA Transcripts158.43K FollowersFollow5ShareSaveCommentsPlay Earnings CallPlay Earnings Call NeuroOne Medical Technologies Corporation (NMTC) Q1 2026 Earnings Call February 17, 2026 8:30 AM EST Company Participants David Rosa - President, CEO & DirectorRonald McClurg - Chief Financial Officer Conference Call Participants Jeffrey Cohen - Ladenburg Thalmann & Co. Inc., Research DivisionJeremy Pearlman - Maxim Group LLC, Research Division Presentation Operator Good day, ladies and gentlemen, and welcome to the First Quarter Fiscal 2026 Financial Results Conference Call for NeuroOne Medical Technologies Corporation. Today's call will be conducted by the company's Chief Executive Officer, Dave Rosa, and Ron McClurg, the company's Chief Financial Officer. Before I turn the call over to Mr. Rosa, I'd like to remind you that this conference call will include forward-looking statements within the meaning of U.S. federal securities laws with respect to future operations financial results, including our 2026 revenue guidance, events, trends and performance, which are based on management's beliefs and assumptions as of today's call. Forward-looking statements may involve known and unknown risks, uncertainties and other factors, which may cause actual results to differ materially from those expressed or implied by such statements. See NeuroOne's financial results press release and SEC filings for information regarding specific risks and uncertainties that could cause actual results to differ. Except as required by law, NeuroOne undertakes no obligation to update such forward-looking statements. With that, I will turn the call over to Mr. Dave Rosa, CEO of NeuroOne. Please go ahead, sir. David RosaPresident, CEO & Director Thank you, operator, and thank you to everyone for joining us today. I'd like to welcome you to our first quarter fiscal 2026 financial results conference call. The company continued the positive momentum from fiscal year 2025 by making progress in a number of different areas of the business. Our first quarter sales were sequentially higher
Source Information
Discussion
0 professional contributions
Sign in to join this professional discussion.
Be the first to add a constructive contribution.
